Lea Krutzke

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

An Aptamer-Based gFET-Sensor for Specific Quantification of Gene Therapeutic Human Adenovirus Type 5.

An Aptamer-Based gFET-Sensor for Specific Quantification of Gene Therapeutic Human Adenovirus Type 5.

Journal: Biosensors

Published: July 08, 2025

An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting.

An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting.

Journal: Molecular therapy. Oncology

Published: May 23, 2024

Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice.

Heterologous DNA-prime/protein-boost immunization with a monomeric SARS-CoV-2 spike antigen redundantizes the trimeric receptor-binding domain structure to induce neutralizing antibodies in old mice.

Journal: Frontiers in immunology

Published: May 30, 2023

Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer.

Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer.

Journal: International journal of molecular sciences

Published: May 10, 2023

Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas.

Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas.

Journal: Viruses

Published: December 01, 2022

Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor.

Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor.

Journal: Biomaterials advances

Published: August 01, 2022

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine.

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine.

Journal: eLife

Published: March 09, 2022

Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells.

Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells.

Journal: Molecular therapy. Methods & clinical development

Published: January 10, 2022

Vaccine-induced COVID-19 mimicry syndrome.

Vaccine-induced COVID-19 mimicry syndrome.

Journal: eLife

Published: October 25, 2021

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.

Journal: Blood

Published: July 06, 2021

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies.

Journal: Viruses

Published: June 02, 2021

Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells.

Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells.

Journal: Viruses

Published: April 30, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026